Related Experiment Video
Updated: Apr 5, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Effective cutaneous vaccination using an inactivated chikungunya virus vaccine delivered by Foroderm
Penny A Rudd1, Anthony P Raphael2, Miko Yamada2
1Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane 4029, QLD, Australia.
Abstract:
Foroderm is a new cutaneous delivery technology that uses high-aspect ratio, cylindrical silica microparticles, that are massaged into the skin using a 3D-printed microtextured applicator, in order to deliver payloads across the epidermis. Herein we show that this technology is effective for delivery of a non-adjuvanted, inactivated, whole-virus chikungunya virus vaccine in mice, with minimal post-vaccination skin reactions. A single topical Foroderm-based vaccination induced T cell, Th1 cytokine and antibody responses, which provided complete protection against viraemia and disease after challenge with chikungunya virus. Foroderm vaccination was shown to deliver fluorescent, virus-sized beads across the epidermis, with beads subsequently detected in draining lymph nodes. Foroderm vaccination also stimulated the egress of MHC II(+) antigen presenting cells from the skin. Foroderm thus has potential as a simple, cheap, effective, generic, needle-free technology for topical delivery of vaccines.

